Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria [NA]

View source ↗

Summary

Completed clinical trial comparing high-dose bilastine (40 mg) to bilastine (20 mg) plus levocetirizine (5 mg) for chronic spontaneous urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bilastine (bilastine)
  • Levocetirizine (Levocetirizine)

Snippet

Sponsor: Derma Techno Pakistan | Conditions: Chronic Spontaneous Urticaria (CSU) | NA | Status: COMPLETED